Lactose (India) Ltd | 141 Cr. | 100 | 247/84.3 | 27.3 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 4.72 Cr. | 2.47 | 4.33/2.47 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 36.6 Cr. | 49.4 | 94.9/45.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 31.7 Cr. | 21.6 | 29.1/13.1 | 31.1 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 62.2 Cr. | 82.6 | 155/79.0 | 14.2 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 58,821 Cr. | 2,084 | 2,286/1,275 | 44.6 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 287 Cr. | 12.6 | 29.0/11.2 | 17.8 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 27.1/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 471 Cr. | 998 | 1,020/635 | 20.1 | 299 | 0.07 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 137 Cr. | 27.4 | 32.0/15.0 | 41.9 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,065 Cr. | 362 | 449/219 | 13.2 | 123 | 0.69 % | 23.0 % | 24.7 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 8.96 Cr. | 3.60 | 9.64/2.11 | 99.6 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 311 Cr. | 320 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,670 Cr. | 1,303 | 1,584/1,078 | 59.8 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 158 Cr. | 0.85 | 1.37/0.53 | 21.0 | 1.12 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 53.9 Cr. | 22.4 | 26.3/6.40 | 55.6 | 16.0 | 0.00 % | 6.11 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 11.5 Cr. | 11.3 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 205 Cr. | 574 | 999/561 | 8.29 | 563 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 56.0 Cr. | 56.0 | 67.0/26.1 | 187 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.9 Cr. | 43.5 | 88.7/37.9 | 41.4 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 8.20 Cr. | 3.28 | 20.8/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.8 Cr. | 125 | 154/58.1 | 55.3 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 22.5 Cr. | 41.2 | 42.0/6.08 | 751 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.5 Cr. | 55.0 | 85.5/0.00 | 48.3 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.96 Cr. | 19.9 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,963 Cr. | 805 | 1,028/453 | 39.0 | 65.3 | 0.12 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 96.6 Cr. | 22.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 10.6 Cr. | 21.0 | 46.0/17.4 | 18.4 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 176 Cr. | 305 | 418/241 | 18.9 | 119 | 1.48 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 53.9 Cr. | 37.6 | 62.6/14.8 | 135 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 63,624 Cr. | 1,086 | 1,593/994 | 18.2 | 557 | 0.39 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 171 Cr. | 274 | 303/156 | 92.8 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 969 Cr. | 96.7 | 124/74.0 | 23.4 | 32.5 | 1.55 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 40.0 Cr. | 30.7 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.68 Cr. | 0.71 | 1.45/0.62 | 93.7 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 253 Cr. | 33.0 | 69.9/31.6 | 29.3 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.16 Cr. | 15.6 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 103 Cr. | 4.38 | 6.25/2.82 | 188 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 71,739 Cr. | 33,759 | 37,000/25,260 | 50.7 | 1,992 | 1.40 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,946 Cr. | 877 | 972/521 | 29.2 | 220 | 0.33 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 190 Cr. | 67.0 | 75.8/31.3 | 47.2 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 3,649 Cr. | 1,226 | 1,305/535 | | 78.1 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 26,558 Cr. | 1,634 | 1,870/835 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 881 Cr. | 268 | 330/154 | 28.9 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 708 Cr. | 530 | 568/270 | 18.9 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 4,290 Cr. | 609 | 950/528 | 31.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,794 Cr. | 1,270 | 1,923/991 | 25.2 | 754 | 0.78 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,24,189 Cr. | 3,670 | 3,790/2,886 | 61.5 | 224 | 0.87 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 978 Cr. | 106 | 317/106 | 32.8 | 43.7 | 0.48 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,700 Cr. | 18.1 | 27.9/14.1 | 34.7 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,931 Cr. | 272 | 303/102 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,90,096 Cr. | 1,626 | 1,960/1,553 | 34.0 | 301 | 0.96 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,712 Cr. | 616 | 886/441 | 111 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,056 Cr. | 232 | 398/175 | 30.1 | 75.9 | 0.17 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 336 Cr. | 1,111 | 1,750/862 | 17.9 | 650 | 0.13 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,557 Cr. | 875 | 1,003/530 | 95.6 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,262 Cr. | 170 | 241/111 | 195 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 12,851 Cr. | 5,580 | 7,600/4,146 | 36.0 | 340 | 2.14 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,880 Cr. | 2,346 | 2,977/1,772 | 37.5 | 321 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 9,877 Cr. | 5,950 | 6,176/4,863 | 38.0 | 323 | 1.37 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 229 Cr. | 64.9 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 23,240 Cr. | 5,080 | 6,453/3,701 | 36.2 | 922 | 0.67 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 9.26 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,498 Cr. | 408 | 582/132 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,941 Cr. | 777 | 1,998/604 | 39.6 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 16,719 Cr. | 13,032 | 18,100/9,192 | 127 | 1,188 | 0.11 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 366 Cr. | 16.3 | 56.5/15.5 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 16,835 Cr. | 940 | 1,639/660 | 8.97 | 425 | 1.02 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,197 Cr. | 58.3 | 101/41.7 | 27.1 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 10,194 Cr. | 225 | 359/168 | 26.8 | 54.4 | 0.35 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 139 Cr. | 87.5 | 145/65.5 | 20.0 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 419 Cr. | 118 | 177/90.2 | 53.0 | 29.0 | 0.00 % | 9.91 % | 9.21 % | 10.0 |
Lupin Ltd | 85,638 Cr. | 1,875 | 2,403/1,774 | 26.4 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,072 Cr. | 535 | 980/499 | 13.0 | 335 | 0.34 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 46,560 Cr. | 862 | 923/390 | 91.4 | 84.6 | 0.14 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,176 Cr. | 1,134 | 1,235/483 | 29.5 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 170 Cr. | 78.7 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 771 Cr. | 160 | 370/155 | 22.1 | 107 | 1.88 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 785 Cr. | 449 | 500/265 | 31.5 | 116 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,485 Cr. | 1,160 | 1,310/802 | 38.3 | 393 | 0.42 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 27,087 Cr. | 1,733 | 2,030/1,303 | 39.6 | 221 | 0.90 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,817 Cr. | 273 | 328/140 | 42.6 | 36.1 | 0.71 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 36,911 Cr. | 1,455 | 1,758/1,168 | 43.6 | 274 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,984 Cr. | 102 | 108/57.5 | 29.5 | 57.5 | 0.94 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 91.3 Cr. | 16.8 | 34.7/12.0 | 11.7 | 74.3 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 655 Cr. | 108 | 186/67.2 | 7.90 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,872 Cr. | 311 | 388/190 | | 111 | 0.48 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,042 Cr. | 328 | 465/309 | 44.5 | 102 | 0.37 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,623 Cr. | 1,908 | 3,257/1,243 | 58.4 | 369 | 0.38 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,890 Cr. | 388 | 504/285 | 55.6 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 11,092 Cr. | 457 | 725/412 | 23.0 | 153 | 0.32 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 58,726 Cr. | 2,081 | 2,286/1,275 | 44.6 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 52,762 Cr. | 3,114 | 3,516/1,921 | 60.4 | 115 | 1.30 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 32,984 Cr. | 2,002 | 2,221/1,200 | 30.3 | 592 | 0.88 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 7,752 Cr. | 476 | 659/359 | 29.0 | 140 | 1.06 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 24,637 Cr. | 1,809 | 1,910/1,035 | 70.3 | 210 | 0.41 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,02,119 Cr. | 1,224 | 1,421/1,020 | 18.1 | 402 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,951 Cr. | 252 | 308/161 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,22,172 Cr. | 1,512 | 1,702/1,310 | 22.8 | 386 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,313 Cr. | 2,015 | 2,641/1,452 | 28.6 | 375 | 0.24 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 465 Cr. | 158 | 203/94.2 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,834 Cr. | 174 | 191/105 | 17.2 | 99.7 | 0.28 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.6 Cr. | 44.0 | 92.0/40.4 | 128 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 51,881 Cr. | 388 | 406/291 | 52.6 | 180 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,746 Cr. | 1,730 | 2,215/1,144 | 38.1 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 156 Cr. | 98.0 | 158/76.3 | 21.6 | 48.6 | 1.23 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 202 Cr. | 85.5 | 95.0/67.8 | 32.1 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,730 Cr. | 9,092 | 10,691/6,220 | 130 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 1,937 Cr. | 670 | 863/544 | 38.1 | 113 | 0.69 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 213 Cr. | 101 | 145/90.1 | 10.8 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 58,348 Cr. | 4,880 | 6,440/4,492 | 27.0 | 1,002 | 0.91 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,677 Cr. | 950 | 1,304/725 | 32.9 | 264 | 1.14 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 511 Cr. | 895 | 1,754/763 | 30.0 | 688 | 0.56 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 33,814 Cr. | 2,707 | 3,486/2,022 | 36.4 | 303 | 1.32 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 4,027 Cr. | 360 | 571/258 | 30.8 | 127 | 1.43 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,596 Cr. | 500 | 635/312 | 25.7 | 136 | 0.20 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,943.28 Cr | 1,196.61 | | 53.48 | 193.55 | 0.31% | 16.61% | 15.24% | 6.18 |